Concepedia

Jan M. Keppel Hesselink

JM

32

Publications

873

Citations

19

H-Index

1985

Active since

Affiliations

Jeroen Bosch Ziekenhuis(Current)

Amsterdam Institute for Addiction Research

Witten/Herdecke University

Robert Bosch (Germany)

Los Angeles Clinical Trials

Jan M. Keppel Hesselink is an author at Jeroen Bosch Ziekenhuis specializing in medicine, neuropharmacology, and pharmacology.

ORCID

Top concepts

Publications per year

1985–2020

32

Publications

32

Therapeutic utility of palmitoylethanolamide in the treatment of neuropathic pain associated with various pathological conditions: a case series

Jan M. Keppel Hesselink, Hekker · Journal of Pain Research · 2012 · 79 citations · Full text

A Double-Blind, Placebo-Controlled Study Comparing the Efficacy and Safety of Ipsapirone Versus Lorazepam in Patients With Generalized Anxiety Disorder

Neal R. Cutler, John J. Sramek, Jan M. Keppel Hesselink et al. · Journal of Clinical Psychopharmacology · 1993 · 77 citations

, , +16

New Targets in Pain, Non-Neuronal Cells, and the Role of Palmitoylethanolamide

Jan M. Keppel Hesselink · The Open Pain Journal · 2012 · 55 citations · Full text

, , +25

Analgesic effects of topical ketamine.

Kopsky Dj, Jan M. Keppel Hesselink, Arun Bhaskar et al. · PubMed · 2015 · 53 citations

, , +13

Topical phenytoin for the treatment of neuropathic pain

David J. Kopsky, Jan M. Keppel Hesselink · Journal of Pain Research · 2017 · 39 citations · Full text

Rows per page

1–5 of 32